The Joint Corp. Reports Q4 2023 Revenue $30.6M, Full Year $117.7M, Net Loss $9.8M on Valuation Allowance

JOINT Corp

Q4 2023 revenue grew 11% to $30.6M; system-wide sales up 11% to $133.1M
Full year 2023 revenue increased 16% to $117.7M; system-wide sales rose 12% to $488.0M
Reported net loss of $9.8M for 2023 including $10.8M non-cash valuation allowance; net income of $627K in 2022
Adjusted EBITDA for 2023 was $12.2M, up from $11.5M in 2022; clinic count grew to 935 from 838
Initiated refranchising program for majority of corporate clinics; 2024 guidance for system-wide sales $530M-$545M

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

JOINT Corp reported financial results for the quarter and year ended December 31, 2023.

Period: the quarter and year ended December 31, 2023
Result: reported results

Exact text from the filing

On March 7, 2024, The Joint Corp. (the "Company") issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2023.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

JOINT Corp filing history →

Source: SEC EDGAR

accession 0001171843-24-001235

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.